|
1
|
Lau LM, Dagg RA, Henson JD, Au AY, Royds
JA and Reddel RR: Detection of alternative lengthening of telomeres
by telomere quantitative PCR. Nucleic Acids Res. 41:e342013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Baumann P, Podell E and Cech TR: Human
Pot1 (protection of telomeres) protein: Cytolocalization, gene
structure, and alternative splicing. Mol Cell Biol. 22:8079–8087.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Blasco MA, Lee HW, Hande MP, Samper E,
Lansdorp PM, DePinho RA and Greider CW: Telomere shortening and
tumor formation by mouse cells lacking telomerase RNA. Cell.
91:25–34. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
van Steensel B, Smogorzewska A and de
Lange T: TRF2 protects human telomeres from end-to-end fusions.
Cell. 92:401–413. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee HW, Blasco MA, Gottlieb GJ, Horner JW
II, Greider CW and DePinho RA: Essential role of mouse telomerase
in highly proliferative organs. Nature. 392:569–574. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nguyen BN, Elmore LW and Holt SE:
Mechanism of dominant-negative telomerase function. Cell Cycle.
8:3227–3233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ozturk S, Sozen B and Demir N: Telomere
length and telomerase activity during oocyte maturation and early
embryo development in mammalian species. Mol Hum Reprod. 20:15–30.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Meyerson M, Counter CM, Eaton EN, Ellisen
LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ,
Liu Q, et al: hEST2, the putative human telomerase catalytic
subunit gene, is up-regulated in tumor cells and during
immortalization. Cell. 90:785–795. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakamura TM, Morin GB, Chapman KB,
Weinrich SL, Andrews WH, Lingner J, Harley CB and Cech TR:
Telomerase catalytic subunit homologs from fission yeast and human.
Science. 277:955–959. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
O'Sullivan JN, Bronner MP, Brentnall TA,
Finley JC, Shen WT, Emerson S, Emond MJ, Gollahon KA, Moskovitz AH,
Crispin DA, et al: Chromosomal instability in ulcerative colitis is
related to telomere shortening. Nat Genet. 32:280–284. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Plentz RR, Schlegelberger B, Flemming P,
Gebel M, Kreipe H, Manns MP, Rudolph KL and Wilkens L: Telomere
shortening correlates with increasing aneuploidy of chromosome 8 in
human hepatocellular carcinoma. Hepatology. 42:522–526. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Loayza D and De Lange T: POT1 as a
terminal transducer of TRF1 telomere length control. Nature.
423:1013–1018. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang F, Podell ER, Zaug AJ, Yang Y, Baciu
P, Cech TR and Lei M: The POT1-TPP1 telomere complex is a
telomerase processivity factor. Nature. 445:506–510. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Latrick CM and Cech TR: POT1-TPP1 enhances
telomerase processivity by slowing primer dissociation and aiding
translocation. EMBO J. 29:924–933. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baumann P and Cech TR: Pot1, the putative
telomere end-binding protein in fission yeast and humans. Science.
292:1171–1175. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Veldman T, Etheridge KT and Counter CM:
Loss of hPot1 function leads to telomere instability and a cut-like
phenotype. Curr Biol. 14:2264–2270. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Armbruster BN, Linardic CM, Veldman T,
Bansal NP, Downie DL and Counter CM: Rescue of an hTERT mutant
defective in telomere elongation by fusion with hPot1. Mol Cell
Biol. 24:3552–3561. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Colgin LM, Baran K, Baumann P, Cech TR and
Reddel RR: Human POT1 facilitates telomere elongation by
telomerase. Curr Biol. 13:942–946. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Prather AA, Puterman E, Lin J, O'Donovan
A, Krauss J, Tomiyama AJ, Epel ES and Blackburn EH: Shorter
leukocyte telomere length in midlife women with poor sleep quality.
J Aging Res. 2011:7213902011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zee RY, Michaud SE, Germer S and Ridker
PM: Association of shorter mean telomere length with risk of
incident myocardial infarction: A prospective, nested case-control
approach. Clin Chim Acta. 403:139–141. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lapham K, Kvale MN, Lin J, Connell S,
Croen LA, Dispensa BP, Fang L, Hesselson S, Hoffmann TJ, Iribarren
C, et al: Automated assay of telomere length measurement and
informatics for 100,000 subjects in the genetic epidemiology
research on adult health and aging (GERA) cohort. Genetics.
200:1061–1072. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Naylor LH: Reporter gene technology: The
future looks bright. Biochem Pharmacol. 58:749–757. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miraglia LJ, King FJ and Damoiseaux R:
Seeing the light: Luminescent reporter gene assays. Comb Chem High
Throughput Screen. 14:648–657. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tiffen JC, Bailey CG, Ng C, Rasko JE and
Holst J: Luciferase expression and bioluminescence does not affect
tumor cell growth in vitro or in vivo. Mol Cancer. 9:2992010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wentzensen IM, Mirabello L, Pfeiffer RM
and Savage SA: The association of telomere length and cancer: a
meta-analysis. Cancer Epidemiol Biomarkers Prev. 20:1238–1250.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang CL, Chen XH, Li L, Zhou Y, Wang C
and Hou S: The association between telomere length and cancer
prognosis: Evidence from a meta-analysis. PLoS One.
10:e01331742015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gilson E and Londoño-Vallejo JA: Telomere
length profiles in humans: All ends are not equal. Cell Cycle.
6:2486–2494. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ju Z and Rudolph Lenhard K: Telomere
dysfunction and stem cell ageing. Biochimie. 90:24–32. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xin H, Liu D, Wan M, Safari A, Kim H, Sun
W, O'Connor MS and Songyang Z: TPP1 is a homologue of ciliate
TEBP-beta and interacts with POT1 to recruit telomerase. Nature.
445:559–562. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Izgi A, Gunal A, Yalcin S and Gunduz U:
Telomere 1 (POT1) gene expression and its association with
telomerase activity in colorectal tumor samples with different
pathological features. Biomed Pharmacother. 68:841–846. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Churikov D and Price CM: Pot1 and cell
cycle progression cooperate in telomere length regulation. Nat
Struct Mol Biol. 15:79–84. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Possemato R, Timmons JC, Bauerlein EL,
Wada N, Baldwin A, Masutomi K and Hahn WC: Suppression of hPOT1 in
diploid human cells results in an hTERT-dependent alteration of
telomere length dynamics. Mol Cancer Res. 6:1582–1593. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Butler KS, Hines WC, Heaphy CM and
Griffith JK: Coordinate regulation between expression levels of
telomere-binding proteins and telomere length in breast carcinomas.
Cancer Med. 1:165–175. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zimmermann S, Biniossek ML, Maurer C,
Münzer P, Pantic M, Veelken H and Martens UM: Proteomic profiling
in distinct cellular compartments of tumor cells reveals
p53-dependent upregulation of S100A6 upon induction of telomere
dysfunction. Proteomics. 9:5175–5187. 2009. View Article : Google Scholar : PubMed/NCBI
|
